Concourse Financial Group Securities’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-154
Closed -$4.46K 2339
2023
Q3
$4.93K Sell
154
-37
-19% -$1.43K ﹤0.01% 1825
2023
Q2
$8.38K Sell
191
-13
-6% -$599 ﹤0.01% 1704
2023
Q1
$9.04K Sell
204
-65
-24% -$2.87K ﹤0.01% 1693
2022
Q4
$10.7K Sell
269
-55
-17% -$2.29K ﹤0.01% 1633
2022
Q3
$15K Buy
324
+17
+6% +$834 ﹤0.01% 1381
2022
Q2
$13K Sell
307
-40
-12% -$1.83K ﹤0.01% 1581
2022
Q1
$19K Sell
347
-364
-51% -$18.6K ﹤0.01% 1501
2021
Q4
$43K Sell
711
-58
-8% -$3.61K ﹤0.01% 1344
2021
Q3
$50K Buy
769
+17
+2% +$1.1K ﹤0.01% 1310
2021
Q2
$48K Buy
752
+151
+25% +$8.68K ﹤0.01% 1333
2021
Q1
$29K Buy
601
+337
+128% +$16.2K ﹤0.01% 1441
2020
Q4
$11K Buy
264
+191
+262% +$8.76K ﹤0.01% 1653
2020
Q3
$3K Buy
73
+38
+109% +$1.76K ﹤0.01% 1943
2020
Q2
$2K Buy
+35
New +$1.57K ﹤0.01% 1909

Other funds holding KIDS

Concourse Financial Group Securities's KIDS Position: Q4 2023 in Review

Concourse Financial Group Securities sold out of OrthoPediatrics (KIDS) in Q4 2023, closing a stake of 154 shares — an estimated $4.46K sold.

Concourse Financial Group Securities first reported a position in KIDS in Q2 2020 and held it in 14 quarters. The position peaked at $50K in Q3 2021. 129 funds tracked by Wall St. Rank hold KIDS as of Q4 2023.

  • Concourse Financial Group Securities reported no remaining OrthoPediatrics position as of Q4 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 154 OrthoPediatrics shares in Q4 2023, an estimated $4.46K.
  • Concourse Financial Group Securities first reported a position in OrthoPediatrics in Q2 2020 and held it in 14 quarters.
  • Concourse Financial Group Securities's OrthoPediatrics position peaked at $50K in Q3 2021.
  • 129 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2023.

Based on Concourse Financial Group Securities's 13F filing for Q4 2023, filed 7 Feb 2024.